Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia

JAMA Neurology

Volumn 71, Issue 10, 2014, Pages 1237-1246

  Fogel, Brent L ^a   Lee, Hane ^a   Deignan, Joshua L ^a   Strom, Samuel P ^a   Kantarci, Sibel ^a   Wang, Xizhe ^a   Quintero Rivera, Fabiola ^a   Vilain, Eric ^a   Grody, Wayne W ^a   Perlman, Susan ^a   Geschwind, Daniel H ^a   Nelson, Stanley F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBELLAR ATAXIA; CHILD; CLINICAL EXOME SEQUENCING; EXOME; FAMILIAL CEREBELLAR ATAXIA; FEMALE; GENE SEQUENCE; GENETIC DISORDER; GENETIC PROCEDURES; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR DIAGNOSIS; ONSET AGE; PRESCHOOL CHILD; SCHOOL CHILD; SPORADIC CEREBELLAR ATAXIA; VERY ELDERLY; YOUNG ADULT; COHORT ANALYSIS; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS; PHENOTYPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEREBELLAR ATAXIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EXOME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84907998240     PISSN: 21686149     EISSN: 21686157     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.1944     Document Type: Article

References (35)

1. Fogel BL, Perlman S. An approach to the patient with late-onset cerebellar ataxia. Nat Clin Pract Neurol. 2006;2(11): 629-635; quiz 621 p following 635.
2. Fogel BL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol. 2007;6(3): 245-257.
3. Fogel BL, Perlman S. Cerebellar disorders: Balancing the approach to cerebellar ataxia. In: Gálvez-Jiménez N, Tuite PJ, eds. Uncommon Causes of Movement Disorders. Cambridge, NY: Cambridge University Press; 2011: 198-216.
4. Fogel BL. Childhood cerebellar ataxia. J Child Neurol. 2012;27(9): 1138-1145.
5. Shakkottai VG, Fogel BL. Clinical neurogenetics: Autosomal dominant spinocerebellar ataxia. Neurol Clin. 2013;31(4): 987-1007.
6. McKusick-Nathans Institute of Genetic Medicine; Johns Hopkins Medicine; National Human Genome Research Institute. Online Mendelian Inheritance in Man. http://omim.org/. Accessed April 1, 2014.
7. Fogel BL, Vickrey BG,Walton-Wetzel J, Lieber E, Browner CH. Utilization of genetic testing prior to subspecialist referral for cerebellar ataxia. Genet Test Mol Biomarkers. 2013;17(8): 588-594.
8. Fogel BL, Geschwind DH. Clinical neurogenetics. In: Daroff R, Fenichel G, Jankovic J, Mazziotta J, eds. Neurology in Clinical Practice. 6th ed. Philadelphia, PA: Elsevier; 2012: 704-734
9. Coppola G, Geschwind DH. Genomic medicine enters the neurology clinic. Neurology. 2012;79(2): 112-114.
10. Fogel BL, Lee JY, Lane J, et al. Mutations in rare ataxia genes are uncommon causes of sporadic cerebellar ataxia. Mov Disord. 2012;27(3): 442-446.
11. Sailer A, Scholz SW, Gibbs JR, et al. Exome sequencing in an SCA14 family demonstrates its utility in diagnosing heterogeneous diseases. Neurology. 2012;79(2): 127-131.
12. Chen Z,Wang JL, Tang BS, et al. Using next-generation sequencing as a genetic diagnostic tool in rare autosomal recessive neurologic Mendelian disorders. Neurobiol Aging. 2013;34(10): 2442.e11-7.
13. Ohba C, Osaka H, Iai M, et al. Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood. Neurogenetics. 2013;14(3-4): 225-232.
14. Sawyer SL, Schwartzentruber J, Beaulieu CL, et al; FORGE Canada Consortium. Exome sequencing as a diagnostic tool for pediatric-onset ataxia. Hum Mutat. 2014;35(1): 45-49.
15. Rehm HL, Bale SJ, Bayrak-Toydemir P, et al; Working Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Commitee. ACMG clinical laboratory standards for next-generation sequencing. Genet Med. 2013;15(9): 733-747.
16. StromSP, Lee H, Das K, et al. Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory. Genet Med. 2014;16(7): 510-515.
17. Sherry ST,Ward MH, KholodovM, et al. dbSNP: The NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1): 308-311.
18. National Heart, Lung and Bood Institute. NHLBI Exome Sequencing Project (ESP) Exome Variant Server. http://evs.gs.washington.edu/EVS/). Accessed December 1, 2013.
19. Abecasis GR, Auton A, Brooks LD, et al; 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422): 56-65.
20. Bamshad MJ, Ng SB, Bigham AW, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011;12(11): 745-755.
21. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11(5): 863-874.
22. González-Pérez A, López-Bigas N. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet. 2011;88(4): 440-449.
23. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damagingmissense mutations. Nat Methods. 2010;7(4): 248-249.
24. Cooper GM, Stone EA, Asimenos G, Green ED, Batzoglou S, Sidow A; NISC Comparative Sequencing Program. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 2005;15(7): 901-913.
25. Fassone E, Rahman S. Complex I deficiency: Clinical features, biochemistry and molecular genetics. J Med Genet. 2012;49(9): 578-590.
26. Johnson JO, Gibbs JR, Megarbane A, et al. Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain. 2012;135(pt 9): 2875-2882.
27. Foley AR, Menezes MP, Pandraud A, et al. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain. 2014;137(pt 1): 44-56.
28. Bernard G, Vanderver A. Pol III-related leukodystrophies. In: Pagon RA, Adam MP, Bird TD, et al, eds. GeneReviews. Seattle,WA: University of Washington, Seattle; 2012.
29. Chaussenot A, Bannwarth S, Rouzier C, et al. Neurologic features and genotype-phenotype correlation inWolfram syndrome. Ann Neurol. 2011; 69(3): 501-508.
30. Tranebjaerg L, Barrett T, Rendtorff ND. WFS1-related disorders. In: Pagon RA, Adam MP, Bird TD, et al, eds. GeneReviews. Seattle,WA: University ofWashington, Seattle; 2013.
31. Stevanin G, Durr A, Brice A. Spastic paraplegia 11. In: Pagon RA, Adam MP, Bird TD, et al, eds. GeneReviews. Seattle,WA: University ofWashington, Seattle; 2013.
32. Gros-Louis F, Dupré N, Dion P, et al. Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia. Nat Genet. 2007;39(1): 80-85.
33. Izumi Y, Miyamoto R, Morino H, et al. Cerebellar ataxia with SYNE1 mutation accompanying motor neuron disease. Neurology. 2013;80(6): 600-601.
34. Noreau A, Bourassa CV, Szuto A, et al. SYNE1 mutations in autosomal recessive cerebellar ataxia. JAMA Neurol. 2013;70(10): 1296-31.
35. Németh AH, Kwasniewska AC, Lise S, et al; UK Ataxia Consortium. Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a model. Brain. 2013;136(pt 10): 3106-3118.